LinkedIn Profile

Access Springleaf Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:springleaftherapeutics 2426585 Mar 30th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 30th, 2020 06:55PM Mar 30th, 2020 06:55PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 29th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 29th, 2020 07:03PM Mar 29th, 2020 07:03PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 28th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 28th, 2020 07:16PM Mar 28th, 2020 07:16PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 27th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 27th, 2020 07:21PM Mar 27th, 2020 07:21PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 26th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 26th, 2020 06:31PM Mar 26th, 2020 06:31PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 25th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 25th, 2020 04:50PM Mar 25th, 2020 04:50PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 24th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 24th, 2020 01:29PM Mar 24th, 2020 01:29PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 23rd, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 23rd, 2020 06:24PM Mar 23rd, 2020 06:24PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 22nd, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 21st, 2020 09:33PM Mar 22nd, 2020 07:15PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Mar 20th, 2020 12:00AM SpringLeaf Therapeutics 44 0.00 Open Biotechnology Mar 20th, 2020 01:38PM Mar 20th, 2020 01:38PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.